285 related articles for article (PubMed ID: 16416388)
1. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown DR
Folia Neuropathol; 2005; 43(4):229-43. PubMed ID: 16416388
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and neurodegeneration in prion diseases.
Kim JI; Choi SI; Kim NH; Jin JK; Choi EK; Carp RI; Kim YS
Ann N Y Acad Sci; 2001 Apr; 928():182-6. PubMed ID: 11795509
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and the prion protein in transmissible spongiform encephalopathies.
Milhavet O; Lehmann S
Brain Res Brain Res Rev; 2002 Feb; 38(3):328-39. PubMed ID: 11890980
[TBL] [Abstract][Full Text] [Related]
5. Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases.
Arnould H; Baudouin V; Baudry A; Ribeiro LW; Ardila-Osorio H; Pietri M; Caradeuc C; Soultawi C; Williams D; Alvarez M; Crozet C; Djouadi F; Laforge M; Bertho G; Kellermann O; Launay JM; Schmitt-Ulms G; Schneider B
PLoS Pathog; 2021 Oct; 17(10):e1009991. PubMed ID: 34610054
[TBL] [Abstract][Full Text] [Related]
6. Prion proteins meet protein quality control.
Dimcheff DE; Portis JL; Caughey B
Trends Cell Biol; 2003 Jul; 13(7):337-40. PubMed ID: 12837603
[TBL] [Abstract][Full Text] [Related]
7. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
8. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
Jeffrey M; McGovern G; Sisó S; González L
Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
[TBL] [Abstract][Full Text] [Related]
9. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
Leach SP; Salman MD; Hamar D
Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
[TBL] [Abstract][Full Text] [Related]
10. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
11. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
Bate C; Tayebi M; Williams A
BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
[TBL] [Abstract][Full Text] [Related]
12. [The prion protein].
Lehmann S
J Soc Biol; 2002; 196(4):309-12. PubMed ID: 12645301
[TBL] [Abstract][Full Text] [Related]
13. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage.
Béranger F; Crozet C; Goldsborough A; Lehmann S
Biochem Biophys Res Commun; 2008 Sep; 374(1):44-8. PubMed ID: 18602368
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidgenesis in prion disease].
Tsuboi Y
Brain Nerve; 2014 Jul; 66(7):849-55. PubMed ID: 24998829
[TBL] [Abstract][Full Text] [Related]
15. Prion disease: A loss of antioxidant function?
Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
[TBL] [Abstract][Full Text] [Related]
16. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
17. Scrg1 is induced in TSE and brain injuries, and associated with autophagy.
Dron M; Bailly Y; Beringue V; Haeberlé AM; Griffond B; Risold PY; Tovey MG; Laude H; Dandoy-Dron F
Eur J Neurosci; 2005 Jul; 22(1):133-46. PubMed ID: 16029203
[TBL] [Abstract][Full Text] [Related]
18. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
19. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
Sakudo A; Ikuta K
Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
[TBL] [Abstract][Full Text] [Related]
20. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
